The global Peptide Analysis market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Peptide Analysis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Peptide Analysis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Peptide Analysis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Peptide Analysis players cover Thermo Fisher Scientific, Roche, NIHON KOHDEN, Hipro, Agappe Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧eptide Analysis Industry Forecast鈥� looks at past sales and reviews total world Peptide Analysis sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Analysis sales for 2025 through 2031. With Peptide Analysis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Analysis industry.
This Insight Report provides a comprehensive analysis of the global Peptide Analysis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Analysis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Peptide Analysis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Analysis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Analysis.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Analysis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Instruments and Reagents
Software
Segmentation by Application:
Hospitals
Clinics
Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Roche
NIHON KOHDEN
Hipro
Agappe Diagnostics
Goldsite Diagnostics
Meril Life Sciences
T&D Diagnostics
Sysmex
Paramedica
Beta Lab Group
Siemens Healthineers
Shenzhen Lifotronic Technology
Shenzhen Poweray Biotechnology
Genrui Biotech
Perlong Medical
Zhuhai Lituo BIOTECHNOLOGY
Edan Instruments
ShenZhen HuiSong Technology Development
Better Life Medical Technology
Shenzhen Ultra-Diagnostics Biotec
Shenzhen Xilaiheng Medical Electronic
ARI Medical
Shanghai Chemira Medpharma
Chongqing Biostec Biological Technology
Shenzhen Meiqiao Medical Technology
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Peptide Analysis 麻豆原创 Size (2020-2031)
2.1.2 Peptide Analysis 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Peptide Analysis by Country/Region (2020, 2024 & 2031)
2.2 Peptide Analysis Segment by Type
2.2.1 Instruments and Reagents
2.2.2 Software
2.3 Peptide Analysis 麻豆原创 Size by Type
2.3.1 Peptide Analysis 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Peptide Analysis 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Peptide Analysis Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Laboratories
2.5 Peptide Analysis 麻豆原创 Size by Application
2.5.1 Peptide Analysis 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Peptide Analysis 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Peptide Analysis 麻豆原创 Size by Player
3.1 Peptide Analysis 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Peptide Analysis Revenue by Player (2020-2025)
3.1.2 Global Peptide Analysis Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Peptide Analysis Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peptide Analysis by Region
4.1 Peptide Analysis 麻豆原创 Size by Region (2020-2025)
4.2 Global Peptide Analysis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide Analysis 麻豆原创 Size Growth (2020-2025)
4.4 APAC Peptide Analysis 麻豆原创 Size Growth (2020-2025)
4.5 Europe Peptide Analysis 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Peptide Analysis 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Peptide Analysis 麻豆原创 Size by Country (2020-2025)
5.2 Americas Peptide Analysis 麻豆原创 Size by Type (2020-2025)
5.3 Americas Peptide Analysis 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Analysis 麻豆原创 Size by Region (2020-2025)
6.2 APAC Peptide Analysis 麻豆原创 Size by Type (2020-2025)
6.3 APAC Peptide Analysis 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peptide Analysis 麻豆原创 Size by Country (2020-2025)
7.2 Europe Peptide Analysis 麻豆原创 Size by Type (2020-2025)
7.3 Europe Peptide Analysis 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptide Analysis by Region (2020-2025)
8.2 Middle East & Africa Peptide Analysis 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Peptide Analysis 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Peptide Analysis 麻豆原创 Forecast
10.1 Global Peptide Analysis Forecast by Region (2026-2031)
10.1.1 Global Peptide Analysis Forecast by Region (2026-2031)
10.1.2 Americas Peptide Analysis Forecast
10.1.3 APAC Peptide Analysis Forecast
10.1.4 Europe Peptide Analysis Forecast
10.1.5 Middle East & Africa Peptide Analysis Forecast
10.2 Americas Peptide Analysis Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Peptide Analysis Forecast
10.2.2 Canada 麻豆原创 Peptide Analysis Forecast
10.2.3 Mexico 麻豆原创 Peptide Analysis Forecast
10.2.4 Brazil 麻豆原创 Peptide Analysis Forecast
10.3 APAC Peptide Analysis Forecast by Region (2026-2031)
10.3.1 China Peptide Analysis 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Peptide Analysis Forecast
10.3.3 Korea 麻豆原创 Peptide Analysis Forecast
10.3.4 Southeast Asia 麻豆原创 Peptide Analysis Forecast
10.3.5 India 麻豆原创 Peptide Analysis Forecast
10.3.6 Australia 麻豆原创 Peptide Analysis Forecast
10.4 Europe Peptide Analysis Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Peptide Analysis Forecast
10.4.2 France 麻豆原创 Peptide Analysis Forecast
10.4.3 UK 麻豆原创 Peptide Analysis Forecast
10.4.4 Italy 麻豆原创 Peptide Analysis Forecast
10.4.5 Russia 麻豆原创 Peptide Analysis Forecast
10.5 Middle East & Africa Peptide Analysis Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Peptide Analysis Forecast
10.5.2 South Africa 麻豆原创 Peptide Analysis Forecast
10.5.3 Israel 麻豆原创 Peptide Analysis Forecast
10.5.4 Turkey 麻豆原创 Peptide Analysis Forecast
10.6 Global Peptide Analysis Forecast by Type (2026-2031)
10.7 Global Peptide Analysis Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Peptide Analysis Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Peptide Analysis Product Offered
11.1.3 Thermo Fisher Scientific Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Peptide Analysis Product Offered
11.2.3 Roche Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 NIHON KOHDEN
11.3.1 NIHON KOHDEN Company Information
11.3.2 NIHON KOHDEN Peptide Analysis Product Offered
11.3.3 NIHON KOHDEN Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 NIHON KOHDEN Main Business Overview
11.3.5 NIHON KOHDEN Latest Developments
11.4 Hipro
11.4.1 Hipro Company Information
11.4.2 Hipro Peptide Analysis Product Offered
11.4.3 Hipro Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Hipro Main Business Overview
11.4.5 Hipro Latest Developments
11.5 Agappe Diagnostics
11.5.1 Agappe Diagnostics Company Information
11.5.2 Agappe Diagnostics Peptide Analysis Product Offered
11.5.3 Agappe Diagnostics Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Agappe Diagnostics Main Business Overview
11.5.5 Agappe Diagnostics Latest Developments
11.6 Goldsite Diagnostics
11.6.1 Goldsite Diagnostics Company Information
11.6.2 Goldsite Diagnostics Peptide Analysis Product Offered
11.6.3 Goldsite Diagnostics Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Goldsite Diagnostics Main Business Overview
11.6.5 Goldsite Diagnostics Latest Developments
11.7 Meril Life Sciences
11.7.1 Meril Life Sciences Company Information
11.7.2 Meril Life Sciences Peptide Analysis Product Offered
11.7.3 Meril Life Sciences Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Meril Life Sciences Main Business Overview
11.7.5 Meril Life Sciences Latest Developments
11.8 T&D Diagnostics
11.8.1 T&D Diagnostics Company Information
11.8.2 T&D Diagnostics Peptide Analysis Product Offered
11.8.3 T&D Diagnostics Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 T&D Diagnostics Main Business Overview
11.8.5 T&D Diagnostics Latest Developments
11.9 Sysmex
11.9.1 Sysmex Company Information
11.9.2 Sysmex Peptide Analysis Product Offered
11.9.3 Sysmex Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Sysmex Main Business Overview
11.9.5 Sysmex Latest Developments
11.10 Paramedica
11.10.1 Paramedica Company Information
11.10.2 Paramedica Peptide Analysis Product Offered
11.10.3 Paramedica Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Paramedica Main Business Overview
11.10.5 Paramedica Latest Developments
11.11 Beta Lab Group
11.11.1 Beta Lab Group Company Information
11.11.2 Beta Lab Group Peptide Analysis Product Offered
11.11.3 Beta Lab Group Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Beta Lab Group Main Business Overview
11.11.5 Beta Lab Group Latest Developments
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Information
11.12.2 Siemens Healthineers Peptide Analysis Product Offered
11.12.3 Siemens Healthineers Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Siemens Healthineers Main Business Overview
11.12.5 Siemens Healthineers Latest Developments
11.13 Shenzhen Lifotronic Technology
11.13.1 Shenzhen Lifotronic Technology Company Information
11.13.2 Shenzhen Lifotronic Technology Peptide Analysis Product Offered
11.13.3 Shenzhen Lifotronic Technology Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Shenzhen Lifotronic Technology Main Business Overview
11.13.5 Shenzhen Lifotronic Technology Latest Developments
11.14 Shenzhen Poweray Biotechnology
11.14.1 Shenzhen Poweray Biotechnology Company Information
11.14.2 Shenzhen Poweray Biotechnology Peptide Analysis Product Offered
11.14.3 Shenzhen Poweray Biotechnology Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Shenzhen Poweray Biotechnology Main Business Overview
11.14.5 Shenzhen Poweray Biotechnology Latest Developments
11.15 Genrui Biotech
11.15.1 Genrui Biotech Company Information
11.15.2 Genrui Biotech Peptide Analysis Product Offered
11.15.3 Genrui Biotech Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Genrui Biotech Main Business Overview
11.15.5 Genrui Biotech Latest Developments
11.16 Perlong Medical
11.16.1 Perlong Medical Company Information
11.16.2 Perlong Medical Peptide Analysis Product Offered
11.16.3 Perlong Medical Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Perlong Medical Main Business Overview
11.16.5 Perlong Medical Latest Developments
11.17 Zhuhai Lituo BIOTECHNOLOGY
11.17.1 Zhuhai Lituo BIOTECHNOLOGY Company Information
11.17.2 Zhuhai Lituo BIOTECHNOLOGY Peptide Analysis Product Offered
11.17.3 Zhuhai Lituo BIOTECHNOLOGY Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Zhuhai Lituo BIOTECHNOLOGY Main Business Overview
11.17.5 Zhuhai Lituo BIOTECHNOLOGY Latest Developments
11.18 Edan Instruments
11.18.1 Edan Instruments Company Information
11.18.2 Edan Instruments Peptide Analysis Product Offered
11.18.3 Edan Instruments Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Edan Instruments Main Business Overview
11.18.5 Edan Instruments Latest Developments
11.19 ShenZhen HuiSong Technology Development
11.19.1 ShenZhen HuiSong Technology Development Company Information
11.19.2 ShenZhen HuiSong Technology Development Peptide Analysis Product Offered
11.19.3 ShenZhen HuiSong Technology Development Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 ShenZhen HuiSong Technology Development Main Business Overview
11.19.5 ShenZhen HuiSong Technology Development Latest Developments
11.20 Better Life Medical Technology
11.20.1 Better Life Medical Technology Company Information
11.20.2 Better Life Medical Technology Peptide Analysis Product Offered
11.20.3 Better Life Medical Technology Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Better Life Medical Technology Main Business Overview
11.20.5 Better Life Medical Technology Latest Developments
11.21 Shenzhen Ultra-Diagnostics Biotec
11.21.1 Shenzhen Ultra-Diagnostics Biotec Company Information
11.21.2 Shenzhen Ultra-Diagnostics Biotec Peptide Analysis Product Offered
11.21.3 Shenzhen Ultra-Diagnostics Biotec Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 Shenzhen Ultra-Diagnostics Biotec Main Business Overview
11.21.5 Shenzhen Ultra-Diagnostics Biotec Latest Developments
11.22 Shenzhen Xilaiheng Medical Electronic
11.22.1 Shenzhen Xilaiheng Medical Electronic Company Information
11.22.2 Shenzhen Xilaiheng Medical Electronic Peptide Analysis Product Offered
11.22.3 Shenzhen Xilaiheng Medical Electronic Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.22.4 Shenzhen Xilaiheng Medical Electronic Main Business Overview
11.22.5 Shenzhen Xilaiheng Medical Electronic Latest Developments
11.23 ARI Medical
11.23.1 ARI Medical Company Information
11.23.2 ARI Medical Peptide Analysis Product Offered
11.23.3 ARI Medical Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.23.4 ARI Medical Main Business Overview
11.23.5 ARI Medical Latest Developments
11.24 Shanghai Chemira Medpharma
11.24.1 Shanghai Chemira Medpharma Company Information
11.24.2 Shanghai Chemira Medpharma Peptide Analysis Product Offered
11.24.3 Shanghai Chemira Medpharma Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.24.4 Shanghai Chemira Medpharma Main Business Overview
11.24.5 Shanghai Chemira Medpharma Latest Developments
11.25 Chongqing Biostec Biological Technology
11.25.1 Chongqing Biostec Biological Technology Company Information
11.25.2 Chongqing Biostec Biological Technology Peptide Analysis Product Offered
11.25.3 Chongqing Biostec Biological Technology Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.25.4 Chongqing Biostec Biological Technology Main Business Overview
11.25.5 Chongqing Biostec Biological Technology Latest Developments
11.26 Shenzhen Meiqiao Medical Technology
11.26.1 Shenzhen Meiqiao Medical Technology Company Information
11.26.2 Shenzhen Meiqiao Medical Technology Peptide Analysis Product Offered
11.26.3 Shenzhen Meiqiao Medical Technology Peptide Analysis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.26.4 Shenzhen Meiqiao Medical Technology Main Business Overview
11.26.5 Shenzhen Meiqiao Medical Technology Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.